Mutation detection and inhibitor risk in Iranian patients with Hemophilia A: Six novel mutations

Farzaneh Nasirnejad Sola1, Saeid Morovvati2, Mitra Sabetghadam Moghadam1

  • 1Department of Genetics Faculty of Advanced Sciences and Technology Islamic Azad University of Medical Sciences Tehran Iran.

Clinical Case Reports
|December 28, 2020
PubMed

This investigation facilitates a better understanding of inhibitor development, the critical treatment morbidity in HA patients. Furthermore, six novel mutations are reported, which would expand the mutation spectrum of the F8 gene.